Q&A: George Church on Genomics of Cognitive Enhancement
Bill of Health
JUNE 12, 2024
In these spin-offs, does one approach the Church Lab with a request for licensing or are there collaboration agreements with the Harvard Office of Technology Review? The practicality I’ve noticed over the years is that no matter what we aim at, there’s the very severe, shorter-term FDA trial. In 2014 CRISPR gene drives.
Let's personalize your content